Trial intelligence / Profile preview

Tegileridine for pain after abdominal surgery

NCT04766463Phase 3Completed

Sponsor
Hengrui
Start
Mar 2021
Primary completion
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tegileridine in acute postoperative pain, sponsored by Hengrui. Started Mar 2021; status: completed.

02

Drugs

tegileridine
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on NCT04766463.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04766463.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call